Organism name | Flourensia heterolepis |
---|---|
Genus | Flourensia |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Flourensia |
---|---|
Linked NCBI taxonomy ID | 191157 |
Linked level | genus |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00008127
![]() |
7-Methoxyflavanone
|
CHEMBL9687
|
5 / 6 / 7 | No. 25 | No. 14 |
![]() |
||
C00008126
![]() |
7-Hydroxyflavanone
|
CHEMBL97542
CHEMBL402744 |
C059353
|
9 / 18 / 45 | 1 / 0 | No. 25 | No. 14 |
![]() |
C00008357
![]() |
5,3',4'-Trihydroxy-7-methoxy-8-C-prenylflavanone
|
No. 28 | No. 14 |
![]() |
||||
C00021827
![]() |
Presilphiperfolanol
|
CHEMBL1966097
|
No. 161 | No. 38 |
![]() |
|||
C00012829
![]() |
[2R-(2alpha,4aalpha,5beta,8abeta)]-Decahydro-5-hydroxy-4a-methyl-a,8-bis(methylene)-2-naphthaleneacetic acid
|
No. 978 |
![]() |
|||||
C00002399
![]() |
6-Hydroxytremetone
|
No. 1831 |
![]() |
|||||
C00012849
![]() |
Decahydro-alpha,4a-dimethyl-8-methylene-7-(2-methyl-1-oxopropoxy)-2-naphthaleneacetic acid
|
No. 2241 |
![]() |
|||||
C00012851
![]() |
Decahydro-alpha,4a-dimethyl-8-methylene-7-(1-oxo-3-phenylpropoxy)-2-naphthaleneacetic acid
|
No. 2241 |
![]() |
|||||
C00012847
![]() |
Decahydro-alpha,4a-dimethyl-8-methylene-7-[(3-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid
|
No. 2241 |
![]() |
|||||
C00012848
![]() |
Decahydro-alpha,4a-dimethyl-8-methylene-7-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid
|
No. 2241 |
![]() |
|||||
C00012850
![]() |
Decahydro-alpha,4a-dimethyl-8-methylene-7-(3-methyl-1-oxobutoxy)-2-naphthaleneacetic acid
|
No. 2241 |
![]() |
|||||
C00012831
![]() |
1-Oxo-4(15),11(13)-eudesmadien-12-oic acid
/ [2R-(2alpha,4aalpha,8abeta)]-Decahydro-4a-methyl-a,8-bis(methylene)-5-oxo-2-naphthaleneacetic acid |
No. 3560 |
![]() |
|||||
C00012832
![]() |
1lapha-Hydroxy-4(15)-eudesmen-12-oic acid
/ Decahydro-5-hydroxy-alpha,4a-dimethyl-8-methylene-2-naphthaleneacetic acid |
No. 7253 |
![]() |
|||||
C00012830
![]() |
[2R-[2alpha,4aalpha,5beta(Z),8abeta]]-Decahydro-4a-methyl-alpha,8-bis(methylene)-5-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid
|
No. 7659 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10275 | Androgen receptor | NR3C4 | C00008126 C00008127 | 3 / 4 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00008126 C00008127 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00008126 C00008127 | 2 / 2 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00008126 C00008127 | 1 / 1 |
P04150 | Glucocorticoid receptor | NR3C1 | C00008126 C00008127 | 0 / 1 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00008126 | 4 / 2 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00008126 | 0 / 0 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00008126 | 1 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00008126 | 7 / 37 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00008126
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#133239 | Esophageal cancer |
P04637
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#211980 | Lung cancer |
P04637
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | name | UniProt |
---|---|---|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|